Term
|
Definition
- Neuronal type, ganglion receptor
- Pentamer of (9) α and (3) β subunits
- Located in postganglionic cell body and dendrites, some presynaptic Ach terminals
- Binding --> Open Na, K channel --> depolarization
|
|
|
Term
|
Definition
- Muscle type, end plate receptor
- Found in skeletal muscle end plates
- Binding --> opening of Na, K channels --> depolarization
|
|
|
Term
|
Definition
Located in nerves: CNS, sympathetic postganglionic, some presynaptic
Ligand binding --> formation of IP3 and DAG --> increased intracellular calcium |
|
|
Term
|
Definition
Located in myocardium, smooth muscle, some presynaptic sites
Acts through Gi
Ligand binding --> opening of K+ channels + inhibition of adenylyl cyclase --> decreased cAMP |
|
|
Term
|
Definition
Located in exocrine glands, smooth muscle, and vessels with smooth muscle
Act through Gq
Binding --> formation of IP3 and DAG --> increased intracellular calcium |
|
|
Term
Muscarinic Receptor Agonists |
|
Definition
Choline esters - acetylcholine
Cholinomimetic alkaloids - muscarine, pilocarpine
|
|
|
Term
|
Definition
Muscarinic receptor agonist
Permanently charged quarternary ammonium --> poorly absorbed, can't get into CNS
Hydrolyzed by acetylcholinesterase
Binding to nicotinic receptors inhibited by β group --> selective
Not used therapeutically |
|
|
Term
|
Definition
Muscarinic receptor agonist - choline ester
Used to diagnose asthma
Carbamic acid derivative - resistant to Achesterase hydrolysis |
|
|
Term
|
Definition
Muscarinic receptor agonist - choline ester
Used topically as miotic agent
Glaucoma treatment
Carbamic acid derivative - resistant to Achesterase hydrolysis |
|
|
Term
|
Definition
Muscarinic receptor agonist - choline ester
Used to promote GI and urinary tract motility (must be due to non-obstructive cause)
Usually used post-operative or post-partum |
|
|
Term
|
Definition
Cholinomimetic alkaloids
Quaternary amine --> poorly absorbed
Not used frequently |
|
|
Term
|
Definition
Muscarine receptor agonist -
Cholinomimetic alkaloid
Tertiary amine --> not hydrolyzed by Achesterase
Well absorbed, penetrates CNS
Excreted by kidney
Used as treatment for Sjogren's (sialogogue), miotic agent |
|
|
Term
Effects of muscarinic agonists |
|
Definition
Cardiac slowing, decrease in CO, vasodilation --> fall in arterial pressure
Increase in GI peristalsis, contraction of bladder and bronchial smooth muscle
Stimulation of sweat, lacrimation, salivation, bronchial secretion
Contraction of ciliary muscle (lowers intraocular pressure, good for acute glaucoma) |
|
|
Term
Toxicity of muscarinic agents |
|
Definition
Nausea and vomiting
Salivation
Sweating
Cutaneous vasodilation
Bronchial constriction
Treat with atropine
Some poisonous mushrooms contain muscarine, effects in 15-30 mins |
|
|
Term
Muscarinic Receptor Antagonists |
|
Definition
Little selectivity
Same basic structure as Ach, with aromatic in place of acetyl group |
|
|
Term
|
Definition
Competitive muscarinic antagonist
Tertiary amine
Found in belladonna/nightshade
|
|
|
Term
|
Definition
Competitive muscarinic antagonist
Similar structure to atropine
Well absorbed from gut, conjunctival membrane
Significant CNS absorptio --> sedation
Formulated for transdermal absorption (motion sickness)
Ameliorate nausea from chemotherapy
Duration of effect: 3 to 7 days
|
|
|
Term
Pharmacological effects of atropine |
|
Definition
Dry as a bone, blind as a bat, red as a beet, mad as a hatter
Inhibition of secretions - salivary, bronchial, lacrimal, sweat
Tachycardia - inhibits parasympathetic tone
Mydriasis - dilation of pupil
Cycloplegia - paralysis of accomodation
Inhibition of GI motility
Relaxation of bronchial, biliary, urinary smooth muscle
Excitatory effects on CNS
Duration of effects: 7 to 10 days |
|
|
Term
Therapeutic uses for atropine |
|
Definition
Induce myadriasis for opthalmologic exam
Reverse sinus bradycardia
Inhibit excessive salivation/mucus
Prevent vagal reflex
Counteract effects of muscarine poisoning |
|
|
Term
|
Definition
Competitive muscarinic receptor antagonist
Tertiary amine
Adjunct in therapy of Parkinsons
Used to treat acute dystonia caused by antipsych meds |
|
|
Term
|
Definition
Competitive antagonist of muscarinic receptor
Quaternary amine --> low CNS penetration
Used to decrease oral secretion
Decrease GI spasm
Treat peptic ulcer
Prevent bradycardia |
|
|
Term
|
Definition
Competitive antagonist of muscarinic receptor
M3 specificity
Tertiary amine
Relief of bladder spasm of urological surgery |
|
|
Term
|
Definition
Competitive antagonist of muscarinic receptor
M3 selectivity
Tertiary amine
Similar to darifenacin, xerostomia
Used for urinary incontinence |
|
|
Term
|
Definition
Competitive inhibitor of muscarinic receptor
Synthetic analog of atropine
Little effect on smooth muscle/CNS
Used in peptic ulcer disease |
|
|
Term
Clinical Uses of Muscarinic Antagonists |
|
Definition
Cardiovascular - atropine for bradycardia
Opthalmic - tropicamide - dilate a pupil
Neuro - scopolamine for motion sickness, benzotropine for parkinsonism
Respiratory - iaptropium for COPD, asthma |
|
|
Term
Nicotinic Receptor Agonists |
|
Definition
|
|
Term
|
Definition
Nicotinic receptor agonist
Liquid .: easily absorbed across all surfaces
Acute nicotine toxicity - 40 mg
Ingestion -> vomiting
CNS stimulation:
seizures, coma, respiratory paralysis, hypertension, arrhythmia |
|
|
Term
Nicotinic Receptor Antagonists |
|
Definition
Ganglion blocking drugs
Neuromuscular blocking drugs |
|
|
Term
|
Definition
Type of nicotinic receptor antagonist
Used to be used for HTN, too much toxicity
Toxicity: cycloplegia, orthostatic hypotension, constipation, urinary retention, sexual dys. |
|
|
Term
|
Definition
Ganglion blocking drug, nicotinic receptor antagonist
Used occasionally in treatment of hypertensive emergencies or dissecting aortic aneurysm |
|
|
Term
Neuromuscular Blocking Drugs
|
|
Definition
Type of nicotinic receptor antagonist
Facilitate surgery, esp intraabd or intrathoracic
Used to control ventilation |
|
|
Term
Neuromuscular blocking drugs
Nicotinic antagonists |
|
Definition
Nondepolarizing neuromuscular blocking drugs
Type of nicotinic receptor antagonist
Block Ach from binding to receptor
Prevent depolarization
Block channel in its closed position |
|
|
Term
|
Definition
Nicotinic antagonist
Non depolarizing neuromuscular blocking drug
Isoquinoline derivative |
|
|
Term
|
Definition
Nondepolarizing neuromuscular blocking drug
Nicotinic antagonist
Steroid derivative |
|
|
Term
Nicotinic agonists - mechanism |
|
Definition
More nicotinic agonists → Increased receptor stimulation → Channel stuck open → Continuous depolarization → Inactivation of voltage gated sodium channels → Paralysis
Can occur with anything that overwhelms the receptor
Examples: acetylcholine, succinylcholine
|
|
|
Term
Nicotinic agonists - Pharmacology |
|
Definition
1-2 quaternary nitrogens → poorly lipid-soluble
Limit CNS entry
Highly polar
Inactive orally - must be administered parenterally
Volume distribution only slightly larger than plasma volume |
|
|
Term
Major chemical classes of nondepolarizing drugs |
|
Definition
Isoquinoline derivatives - tubocurarine
Steroid derivatives - pancuronium |
|
|
Term
|
Definition
Two molecules of Ach linked end to end
Slowly hydrolyzed by acetylcholinesterase
Quickly eliminated by plasma cholinesterase
Short duration of action (5 to 10 mins)
|
|
|
Term
Cholinesterase Inhibitors - Mechanism |
|
Definition
Bind to and inhibit acetylcholinesterase
Increase level of acetylcholine in synaptic cleft
Activate cholinergic receptors without directly binding to them
|
|
|
Term
Classes of Cholinesterase Inhibitors |
|
Definition
Simple alcohol - edrophonium
Carbamic acid ester - neostigmine, physostigmine
Organophosphates |
|
|
Term
|
Definition
Simple alcohol - cholinesterase inhibitor
Quaternary ammonium
Reversible inhibitor of AchE
Bnds reversibly via electrostatic interactions and hydrogen bonds
Short duration of action - enzyme inhibitor complex persists for 2 to 10 minutes (allows for tight control)
|
|
|
Term
Therapeutic of edrophonium |
|
Definition
Diagnostic test for patients with muscle weakness
Assesses adequacy of treatment for myasthenia gravis |
|
|
Term
|
Definition
Absorption poor due to permanent charge
Negligible CNS distribution |
|
|
Term
Cholinesterase inhibitors for Alzheimers |
|
Definition
Tacrine
Donepezil
Rivastigmine
Galantamine |
|
|
Term
|
Definition
Anticholinesterase used for Alzheimer's
Improves cognitive function
Efficacy modest
Significant hepatic toxicity |
|
|